PRNewswire: September 7, 2016 – VANCOUVER, British Columbia, Canada, and WALNUT CREEK, CA, U.S.A. – DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar”), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, and Accurexa Inc. (OTCQB: ACXA) (“…
